Lagos bat virus in Kenya

During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained from a dead Eidolon helvum fruit bat. The virus was most similar phylogenetically to LBV isolates from Senegal (1985) and from France (import...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical microbiology Ročník 46; číslo 4; s. 1451
Hlavní autori:	Kuzmin, Ivan V, Niezgoda, Michael, Franka, Richard, Agwanda, Bernard, Markotter, Wanda, Beagley, Janet C, Urazova, Olga Y, Breiman, Robert F, Rupprecht, Charles E
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.04.2008
Predmet:	Animals Antibodies, Viral - blood Antigens, Viral - analysis Brain - virology Chiroptera - virology Female Kenya - epidemiology Lyssavirus - classification Lyssavirus - immunology Lyssavirus - isolation & purification Lyssavirus - pathogenicity Male Mice Mice, Inbred ICR Neutralization Tests Rhabdoviridae Infections - epidemiology Rhabdoviridae Infections - veterinary Rhabdoviridae Infections - virology Kenya
ISSN:	1098-660X, 1098-660X
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained from a dead Eidolon helvum fruit bat. The virus was most similar phylogenetically to LBV isolates from Senegal (1985) and from France (imported from Togo or Egypt; 1999), sharing with these viruses 100% nucleoprotein identity and 99.8 to 100% glycoprotein identity. This genome conservancy across space and time suggests that LBV is well adapted to its natural host species and that populations of reservoir hosts in eastern and western Africa have sufficient interactions to share pathogens. High virus concentrations, in addition to being detected in the brain, were detected in the salivary glands and tongue and in an oral swab, suggesting that LBV is transmitted in the saliva. In other extraneural organs, the virus was generally associated with innervations and ganglia. The presence of infectious virus in the reproductive tract and in a vaginal swab implies an alternative opportunity for transmission. The isolate was pathogenic for laboratory mice by the intracerebral and intramuscular routes. Serologic screening demonstrated the presence of LBV-neutralizing antibodies in E. helvum and Rousettus aegyptiacus fruit bats. In different colonies the seroprevalence ranged from 40 to 67% and 29 to 46% for E. helvum and R. aegyptiacus, respectively. Nested reverse transcription-PCR did not reveal the presence of viral RNA in oral swabs of bats in the absence of brain infection. Several large bat roosts were identified in areas of dense human populations, raising public health concerns for the potential of lyssavirus infection.
AbstractList	During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained from a dead Eidolon helvum fruit bat. The virus was most similar phylogenetically to LBV isolates from Senegal (1985) and from France (imported from Togo or Egypt; 1999), sharing with these viruses 100% nucleoprotein identity and 99.8 to 100% glycoprotein identity. This genome conservancy across space and time suggests that LBV is well adapted to its natural host species and that populations of reservoir hosts in eastern and western Africa have sufficient interactions to share pathogens. High virus concentrations, in addition to being detected in the brain, were detected in the salivary glands and tongue and in an oral swab, suggesting that LBV is transmitted in the saliva. In other extraneural organs, the virus was generally associated with innervations and ganglia. The presence of infectious virus in the reproductive tract and in a vaginal swab implies an alternative opportunity for transmission. The isolate was pathogenic for laboratory mice by the intracerebral and intramuscular routes. Serologic screening demonstrated the presence of LBV-neutralizing antibodies in E. helvum and Rousettus aegyptiacus fruit bats. In different colonies the seroprevalence ranged from 40 to 67% and 29 to 46% for E. helvum and R. aegyptiacus, respectively. Nested reverse transcription-PCR did not reveal the presence of viral RNA in oral swabs of bats in the absence of brain infection. Several large bat roosts were identified in areas of dense human populations, raising public health concerns for the potential of lyssavirus infection. During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained from a dead Eidolon helvum fruit bat. The virus was most similar phylogenetically to LBV isolates from Senegal (1985) and from France (imported from Togo or Egypt; 1999), sharing with these viruses 100% nucleoprotein identity and 99.8 to 100% glycoprotein identity. This genome conservancy across space and time suggests that LBV is well adapted to its natural host species and that populations of reservoir hosts in eastern and western Africa have sufficient interactions to share pathogens. High virus concentrations, in addition to being detected in the brain, were detected in the salivary glands and tongue and in an oral swab, suggesting that LBV is transmitted in the saliva. In other extraneural organs, the virus was generally associated with innervations and ganglia. The presence of infectious virus in the reproductive tract and in a vaginal swab implies an alternative opportunity for transmission. The isolate was pathogenic for laboratory mice by the intracerebral and intramuscular routes. Serologic screening demonstrated the presence of LBV-neutralizing antibodies in E. helvum and Rousettus aegyptiacus fruit bats. In different colonies the seroprevalence ranged from 40 to 67% and 29 to 46% for E. helvum and R. aegyptiacus, respectively. Nested reverse transcription-PCR did not reveal the presence of viral RNA in oral swabs of bats in the absence of brain infection. Several large bat roosts were identified in areas of dense human populations, raising public health concerns for the potential of lyssavirus infection.During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained from a dead Eidolon helvum fruit bat. The virus was most similar phylogenetically to LBV isolates from Senegal (1985) and from France (imported from Togo or Egypt; 1999), sharing with these viruses 100% nucleoprotein identity and 99.8 to 100% glycoprotein identity. This genome conservancy across space and time suggests that LBV is well adapted to its natural host species and that populations of reservoir hosts in eastern and western Africa have sufficient interactions to share pathogens. High virus concentrations, in addition to being detected in the brain, were detected in the salivary glands and tongue and in an oral swab, suggesting that LBV is transmitted in the saliva. In other extraneural organs, the virus was generally associated with innervations and ganglia. The presence of infectious virus in the reproductive tract and in a vaginal swab implies an alternative opportunity for transmission. The isolate was pathogenic for laboratory mice by the intracerebral and intramuscular routes. Serologic screening demonstrated the presence of LBV-neutralizing antibodies in E. helvum and Rousettus aegyptiacus fruit bats. In different colonies the seroprevalence ranged from 40 to 67% and 29 to 46% for E. helvum and R. aegyptiacus, respectively. Nested reverse transcription-PCR did not reveal the presence of viral RNA in oral swabs of bats in the absence of brain infection. Several large bat roosts were identified in areas of dense human populations, raising public health concerns for the potential of lyssavirus infection.
Author	Agwanda, Bernard Urazova, Olga Y Kuzmin, Ivan V Franka, Richard Niezgoda, Michael Beagley, Janet C Rupprecht, Charles E Markotter, Wanda Breiman, Robert F
Author_xml	– sequence: 1 givenname: Ivan V surname: Kuzmin fullname: Kuzmin, Ivan V email: ikuzmin@cdc.gov organization: Centers for Disease Control and Prevention, 1600 Clifton Rd., Bldg. 17, MS G-33, Atlanta, GA 30333, USA. ikuzmin@cdc.gov – sequence: 2 givenname: Michael surname: Niezgoda fullname: Niezgoda, Michael – sequence: 3 givenname: Richard surname: Franka fullname: Franka, Richard – sequence: 4 givenname: Bernard surname: Agwanda fullname: Agwanda, Bernard – sequence: 5 givenname: Wanda surname: Markotter fullname: Markotter, Wanda – sequence: 6 givenname: Janet C surname: Beagley fullname: Beagley, Janet C – sequence: 7 givenname: Olga Y surname: Urazova fullname: Urazova, Olga Y – sequence: 8 givenname: Robert F surname: Breiman fullname: Breiman, Robert F – sequence: 9 givenname: Charles E surname: Rupprecht fullname: Rupprecht, Charles E
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/18305130$$D View this record in MEDLINE/PubMed
BookMark	eNpNz7lLxEAYBfBBVtxDOwsrSWWX9Zt7tpSwnhEbBbswxxeJ5FgzibD_vQFXsHqv-PHgLcms7Vok5JzCmlJmrh-z5zUAUJWCOSILChuTKgXvs399TpYxfk5ICClPyJwaDpJyWJCL3H50MXF2SL6rfoxJ1SZP2O7tKTkubR3x7JAr8na7fc3u0_zl7iG7yVMvmRhShV6WCjfSK2V0KIWVIBwG5q3gPujA3OS0s6XzXnPkQnhLKQRLDeOcsRW5-t3d9d3XiHEomip6rGvbYjfGQoPQwA2d4OUBjq7BUOz6qrH9vvj7wn4AqU9Kmw
CitedBy_id	crossref_primary_10_3390_tropicalmed2030037 crossref_primary_10_3161_15081109ACC2017_19_1_006 crossref_primary_10_1016_j_vaccine_2009_09_024 crossref_primary_10_12688_f1000research_10416_1 crossref_primary_10_1371_journal_pone_0030346 crossref_primary_10_3390_vaccines11071255 crossref_primary_10_3390_pathogens12091089 crossref_primary_10_1016_j_vaccine_2015_03_025 crossref_primary_10_1007_s11262_013_0952_9 crossref_primary_10_1371_journal_pntd_0000428 crossref_primary_10_4102_ojvr_v80i1_511 crossref_primary_10_1016_j_virol_2013_03_014 crossref_primary_10_1089_vim_2020_0317 crossref_primary_10_1016_j_vaccine_2016_08_088 crossref_primary_10_1089_vbz_2011_0663 crossref_primary_10_3161_150811014X683291 crossref_primary_10_1016_j_virusres_2011_06_022 crossref_primary_10_1371_journal_pone_0160553 crossref_primary_10_3390_tropicalmed2030026 crossref_primary_10_3390_tropicalmed2030025 crossref_primary_10_3390_tropicalmed2030024 crossref_primary_10_1111_tbed_13826 crossref_primary_10_1586_14760584_7_5_613 crossref_primary_10_3390_v15020498 crossref_primary_10_1016_j_virusres_2012_01_011 crossref_primary_10_3390_pathogens11090975 crossref_primary_10_1371_journal_pone_0011978 crossref_primary_10_3390_v13030391 crossref_primary_10_1128_JVI_02932_14 crossref_primary_10_1016_S1473_3099_17_30574_1 crossref_primary_10_1038_ncomms3770 crossref_primary_10_3390_v11010037 crossref_primary_10_1016_j_virusres_2010_01_018 crossref_primary_10_1017_S0950268812000167 crossref_primary_10_1016_j_virusres_2008_04_021 crossref_primary_10_3201_eid2412_181204 crossref_primary_10_1111_jzo_12769 crossref_primary_10_1371_journal_pntd_0002511 crossref_primary_10_1371_journal_pntd_0006311 crossref_primary_10_3201_eid1412_080750 crossref_primary_10_3201_eid2412 crossref_primary_10_1016_j_biocon_2011_09_003 crossref_primary_10_1371_journal_pntd_0008898 crossref_primary_10_1099_vir_0_061952_0 crossref_primary_10_3390_pathogens14090919 crossref_primary_10_1371_journal_pntd_0003070 crossref_primary_10_1016_j_virol_2010_09_014 crossref_primary_10_3201_eid1602_091269 crossref_primary_10_3201_eid1612_100726 crossref_primary_10_1371_journal_pntd_0006182 crossref_primary_10_1177_03009858241231556 crossref_primary_10_1016_j_virusres_2015_07_009 crossref_primary_10_1111_zph_12000 crossref_primary_10_1371_journal_pntd_0010803 crossref_primary_10_1016_j_heliyon_2024_e26118 crossref_primary_10_1371_journal_pone_0198563 crossref_primary_10_3402_ehtj_v4i0_7159 crossref_primary_10_1016_j_vetmic_2010_02_001 crossref_primary_10_3201_eid1612_100601 crossref_primary_10_2217_fvl_13_60 crossref_primary_10_1016_j_vaccine_2013_05_081 crossref_primary_10_1016_j_virusres_2010_10_023 crossref_primary_10_1007_s10393_009_0263_8 crossref_primary_10_1038_sdata_2016_49 crossref_primary_10_1111_j_1461_0248_2012_01836_x crossref_primary_10_4102_ojvr_v88i1_1911 crossref_primary_10_1111_tbed_13754 crossref_primary_10_1038_s41598_023_42938_w crossref_primary_10_1644_09_MAMM_A_283_1 crossref_primary_10_3201_eid1612_101089 crossref_primary_10_1016_j_jviromet_2011_07_002 crossref_primary_10_3201_eid2001_130813 crossref_primary_10_4061_2011_727821 crossref_primary_10_1016_j_actatropica_2022_106462 crossref_primary_10_1371_journal_pntd_0012171 crossref_primary_10_1099_vir_0_053983_0 crossref_primary_10_1371_journal_pone_0100172 crossref_primary_10_3390_v13040576 crossref_primary_10_1128_JVI_01153_10 crossref_primary_10_3390_v13122378 crossref_primary_10_1016_j_virol_2025_110621
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1128/JCM.00016-08
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Biology
EISSN	1098-660X
ExternalDocumentID	18305130
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	Kenya
GeographicLocations_xml	– name: Kenya
GroupedDBID	--- .55 .GJ 0R~ 18M 29K 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS AAYOK ABOCM ABPPZ ACGFO ADBBV AENEX AGCDD AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CGR CS3 CUY CVF D-I DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HF~ HYE HZ~ H~9 KQ8 L7B NPM O9- OHT OK1 P2P P6G PKN RHF RHI RNS RPM RSF TR2 UCJ VH1 W8F WHG WOQ X7M YIF ZCA ZGI ZXP ~KM 7X8 AAGFI
ID	FETCH-LOGICAL-c524t-6ec5f6e95c6687df4a504bed2ca43cd7d2b5247bafbcc73e344ca110da1823322
IEDL.DBID	7X8
ISICitedReferencesCount	90
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000254866400042&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1098-660X
IngestDate	Fri Sep 05 10:02:24 EDT 2025 Wed Feb 19 01:51:31 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c524t-6ec5f6e95c6687df4a504bed2ca43cd7d2b5247bafbcc73e344ca110da1823322
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	http://hdl.handle.net/2263/7233
PMID	18305130
PQID	70470381
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_70470381 pubmed_primary_18305130
PublicationCentury	2000
PublicationDate	2008-04-01
PublicationDateYYYYMMDD	2008-04-01
PublicationDate_xml	– month: 04 year: 2008 text: 2008-04-01 day: 01
PublicationDecade	2000
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Journal of clinical microbiology
PublicationTitleAlternate	J Clin Microbiol
PublicationYear	2008
References	24228955 - J Wildl Dis. 1977 Oct;13(4):366-9 11238853 - J Virol. 2001 Apr;75(7):3268-76 16705370 - Arch Virol. 2006 Oct;151(10):2021-35 12127791 - Virology. 2002 Jul 5;298(2):286-305 8386891 - Virology. 1993 May;194(1):70-81 12083841 - Virology. 2002 May 25;297(1):109-19 2681843 - J Wildl Dis. 1989 Oct;25(4):490-6 13592882 - Trans R Soc Trop Med Hyg. 1958 Sep;52(5):421-4 11602781 - J Gen Virol. 2001 Nov;82(Pt 11):2691-6 16847127 - J Gen Virol. 2006 Aug;87(Pt 8):2309-21 8578857 - Virus Res. 1995 Oct;38(2-3):175-92 16417429 - Vector Borne Zoonotic Dis. 2005 Winter;5(4):330-41 17848065 - Curr Top Microbiol Immunol. 2007;315:161-93 5530013 - J Virol. 1970 Nov;6(5):690-2 15896401 - Virus Res. 2005 Jul;111(1):44-54 14602198 - Virus Res. 2003 Nov;97(2):65-79 615673 - Bull Soc Pathol Exot Filiales. 1977 Sep-Oct;70(5):467-70 1703959 - Eur J Immunol. 1991 Jan;21(1):1-10 17374776 - J Gen Virol. 2007 Apr;88(Pt 4):1302-14 17495316 - J Wildl Dis. 2007 Apr;43(2):291-9 4967120 - Public Health Rep. 1968 Apr;83(4):303-16 14223126 - N Engl J Med. 1965 Jan 14;272:75-80 15752440 - Emerg Infect Dis. 2005 Feb;11(2):232-6 4200590 - J Infect Dis. 1973 Oct;128(4):471-8 7995360 - Epidemiol Infect. 1994 Dec;113(3):501-11 12367747 - Virus Res. 2002 Oct;89(1):1-28 17370529 - Emerg Infect Dis. 2007 Jan;13(1):136-9 11226582 - Virus Res. 2001 Apr;74(1-2):139-56 11751241 - Bioinformatics. 2001 Dec;17(12):1244-5 2445121 - Virus Res. 1987 Aug;8(2):103-25 1402044 - J Infect Dis. 1992 Nov;166(5):972-7 2161049 - J Gen Virol. 1990 May;71 ( Pt 5):1153-62 7210163 - Trop Geogr Med. 1980 Sep;32(3):265-7 8183914 - Proc Natl Acad Sci U S A. 1994 May 10;91(10):4362-6 16847128 - J Gen Virol. 2006 Aug;87(Pt 8):2323-31 11738736 - Vaccine. 2001 Dec 12;20(5-6):731-6 10727745 - Prev Vet Med. 2000 Mar 29;44(1-2):73-85 1651093 - Biotechniques. 1991 Apr;10(4):484, 486 15638002 - Vet Rec. 2004 Dec 11;155(24):774-7 17326944 - Emerg Infect Dis. 2006 Dec;12(12):1913-8 9847325 - J Virol. 1999 Jan;73(1):225-33 2915390 - J Wildl Dis. 1989 Jan;25(1):10-9 16485470 - Emerg Infect Dis. 2005 Dec;11(12):1854-9 324250 - Adv Virus Res. 1977;21:1-36 6185960 - Proc Natl Acad Sci U S A. 1983 Jan;80(1):70-4 15896400 - Virus Res. 2005 Jul;111(1):28-43 4964117 - Public Health Rep. 1967 Oct;82(10):867-88 4861360 - Nature. 1967 Oct 28;216(5113):384 4551426 - Science. 1972 Mar 17;175(4027):1255-6 16704789 - Emerg Infect Dis. 2006 Mar;12(3):486-8 16704795 - Emerg Infect Dis. 2006 Mar;12(3):504-6
References_xml	– reference: 8183914 - Proc Natl Acad Sci U S A. 1994 May 10;91(10):4362-6 – reference: 17848065 - Curr Top Microbiol Immunol. 2007;315:161-93 – reference: 12127791 - Virology. 2002 Jul 5;298(2):286-305 – reference: 5530013 - J Virol. 1970 Nov;6(5):690-2 – reference: 11226582 - Virus Res. 2001 Apr;74(1-2):139-56 – reference: 13592882 - Trans R Soc Trop Med Hyg. 1958 Sep;52(5):421-4 – reference: 16705370 - Arch Virol. 2006 Oct;151(10):2021-35 – reference: 2681843 - J Wildl Dis. 1989 Oct;25(4):490-6 – reference: 1402044 - J Infect Dis. 1992 Nov;166(5):972-7 – reference: 4551426 - Science. 1972 Mar 17;175(4027):1255-6 – reference: 17374776 - J Gen Virol. 2007 Apr;88(Pt 4):1302-14 – reference: 17370529 - Emerg Infect Dis. 2007 Jan;13(1):136-9 – reference: 11751241 - Bioinformatics. 2001 Dec;17(12):1244-5 – reference: 7210163 - Trop Geogr Med. 1980 Sep;32(3):265-7 – reference: 17495316 - J Wildl Dis. 2007 Apr;43(2):291-9 – reference: 324250 - Adv Virus Res. 1977;21:1-36 – reference: 15896400 - Virus Res. 2005 Jul;111(1):28-43 – reference: 8578857 - Virus Res. 1995 Oct;38(2-3):175-92 – reference: 14602198 - Virus Res. 2003 Nov;97(2):65-79 – reference: 4200590 - J Infect Dis. 1973 Oct;128(4):471-8 – reference: 2161049 - J Gen Virol. 1990 May;71 ( Pt 5):1153-62 – reference: 1651093 - Biotechniques. 1991 Apr;10(4):484, 486 – reference: 14223126 - N Engl J Med. 1965 Jan 14;272:75-80 – reference: 16704789 - Emerg Infect Dis. 2006 Mar;12(3):486-8 – reference: 16485470 - Emerg Infect Dis. 2005 Dec;11(12):1854-9 – reference: 16847127 - J Gen Virol. 2006 Aug;87(Pt 8):2309-21 – reference: 4861360 - Nature. 1967 Oct 28;216(5113):384 – reference: 2445121 - Virus Res. 1987 Aug;8(2):103-25 – reference: 4967120 - Public Health Rep. 1968 Apr;83(4):303-16 – reference: 7995360 - Epidemiol Infect. 1994 Dec;113(3):501-11 – reference: 10727745 - Prev Vet Med. 2000 Mar 29;44(1-2):73-85 – reference: 9847325 - J Virol. 1999 Jan;73(1):225-33 – reference: 1703959 - Eur J Immunol. 1991 Jan;21(1):1-10 – reference: 17326944 - Emerg Infect Dis. 2006 Dec;12(12):1913-8 – reference: 12367747 - Virus Res. 2002 Oct;89(1):1-28 – reference: 24228955 - J Wildl Dis. 1977 Oct;13(4):366-9 – reference: 15896401 - Virus Res. 2005 Jul;111(1):44-54 – reference: 8386891 - Virology. 1993 May;194(1):70-81 – reference: 2915390 - J Wildl Dis. 1989 Jan;25(1):10-9 – reference: 16704795 - Emerg Infect Dis. 2006 Mar;12(3):504-6 – reference: 16847128 - J Gen Virol. 2006 Aug;87(Pt 8):2323-31 – reference: 15752440 - Emerg Infect Dis. 2005 Feb;11(2):232-6 – reference: 4964117 - Public Health Rep. 1967 Oct;82(10):867-88 – reference: 12083841 - Virology. 2002 May 25;297(1):109-19 – reference: 6185960 - Proc Natl Acad Sci U S A. 1983 Jan;80(1):70-4 – reference: 16417429 - Vector Borne Zoonotic Dis. 2005 Winter;5(4):330-41 – reference: 11738736 - Vaccine. 2001 Dec 12;20(5-6):731-6 – reference: 11238853 - J Virol. 2001 Apr;75(7):3268-76 – reference: 615673 - Bull Soc Pathol Exot Filiales. 1977 Sep-Oct;70(5):467-70 – reference: 15638002 - Vet Rec. 2004 Dec 11;155(24):774-7 – reference: 11602781 - J Gen Virol. 2001 Nov;82(Pt 11):2691-6
SSID	ssj0014455
Score	2.2734213
Snippet	During lyssavirus surveillance, 1,221 bats of at least 30 species were collected from 25 locations in Kenya. One isolate of Lagos bat virus (LBV) was obtained...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1451
SubjectTerms	Animals Antibodies, Viral - blood Antigens, Viral - analysis Brain - virology Chiroptera - virology Female Kenya - epidemiology Lyssavirus - classification Lyssavirus - immunology Lyssavirus - isolation & purification Lyssavirus - pathogenicity Male Mice Mice, Inbred ICR Neutralization Tests Rhabdoviridae Infections - epidemiology Rhabdoviridae Infections - veterinary Rhabdoviridae Infections - virology
Title	Lagos bat virus in Kenya
URI	https://www.ncbi.nlm.nih.gov/pubmed/18305130 https://www.proquest.com/docview/70470381
Volume	46
WOSCitedRecordID	wos000254866400042&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV05T8MwFH4qFBALRzlazgysoWlsx4mEhFBFhVBbdQCULXJsB3VJSpNW6r_nOYeYEANLpkSK_Q4_-_v8PoA7lcSSE6ltjySBTSUdYB4UGnet6NGJz6go2zF8jPl06odhMGvBQ3MXxtAqm5xYJmqVSXNG3ucO5QbVelx82UYzymCrtYDGFrQJFjKG0MXDHwyB0lLzdGA6ZnqeEza0d9fvvw4n92W1Yzv-76VlucSMDv_3c0dwUJeW1lPlC8fQ0mkHdiuxyU0H9iY1jH4C3bH4zHIrFoW1ni9XuTVPLcy4G3EK76Pnt-GLXUsk2JK5tLA9LVni6YBJz_O5SqhgDo21cqWgRCqu3Bjf47FAk6BNNKFUClzxlcB9BcFgPoPtNEt1FyxOmaZM-lITRpXUgTEUxn_MXcmYYD24bcYeoQsaXEGkOlvlUTP6HpxX0xctqk4ZEeYLDHriXPz57SXsV0wMw4m5gnaCwaevYUeui3m-vCkti8_pbPINVoCrKg
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lagos+bat+virus+in+Kenya&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Kuzmin%2C+Ivan+V&rft.au=Niezgoda%2C+Michael&rft.au=Franka%2C+Richard&rft.au=Agwanda%2C+Bernard&rft.date=2008-04-01&rft.eissn=1098-660X&rft.volume=46&rft.issue=4&rft.spage=1451&rft_id=info:doi/10.1128%2FJCM.00016-08&rft_id=info%3Apmid%2F18305130&rft_id=info%3Apmid%2F18305130&rft.externalDocID=18305130
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-660X&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-660X&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-660X&client=summon